Skip to content

Discovery and validation of new targets and markers based on pulmonary fibrosis

Discovery and validation of new targets and markers based on pulmonary fibrosis

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300076235
Enrollment
Unknown
Registered
2023-09-27
Start date
2023-09-30
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Fibrosis

Interventions

Pulmonary nodules group (healthy control group):None

Sponsors

Shanghai Pulmonary Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Experimental group: 1. Cases included in the experimental group met the diagnostic criteria for pulmonary fibrosis; 2. Aged 18-80 years; 3. Did not participate in any other drug clinical study within 1 month before enrollment; 4. Voluntarily participated in this study and patients signed an informed consent form. Control group: 1. Pulmonary nodules detected by chest examination and proposed surgery for pulmonary nodules (wedge resection, segmental resection, lobectomy, etc.); 2. Aged 18-80 years old; 3. Not participating in any other drug clinical study within 1 month prior to enrollment; 4. Voluntarily participate in this study and participants sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Pregnant or breastfeeding women and patients with recent pregnancy plans; 2. Participants with delirium, dementia, and various psychiatric disorders; 3. Participants with severe disorders of consciousness.

Design outcomes

Primary

MeasureTime frame
Related gene expression;

Countries

China

Contacts

Public ContactHong Shi

Shanghai Pulmonary Hospital

ada-shi@139.com+86 136 5195 8255

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026